MedPath

NAPROXEN CAPSULES 200 MG

NAPROXEN CAPSULES 200 MG

Discontinued
DIN Number

02422743

Drug Class

Human

Market Date

N/A

Company
HC

Accucaps Industries Ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02422743
AIG Number0255210001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
M01AE02 NAPROXEN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (2)

NAPROXENActive
Strength: 105 MG
Monograph: NAPROXEN
NAPROXEN SODIUMActive
Strength: 105 MG
Monograph: NAPROXEN SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.